<?xml version="1.0" ?>
<TimeML xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://timeml.org/timeMLdocs/TimeML_1.2.1.xsd">

<DOCID>695204138228</DOCID>

<DCT><TIMEX3 tid="t0" type="DATE" value="20170129" temporalFunction="false" functionInDocument="CREATION_TIME">January 29, 2017</TIMEX3></DCT>

<TITLE>IJMS, Vol. 18, Pages 294: Metabolomic Biomarkers in Urine of Cushings Syndrome Patients</TITLE>


<TEXT>
Open Access Article 
 
Int. J. Mol. Sci.  2017 , 18 (2), 294; doi:10.3390/ijms18020294 (<EVENT eid="e1" class="OCCURRENCE">registering</EVENT> DOI) 
    
1 
 
Department of Food Sciences, Faculty of Pharmacy, Medical University of Gdask, Al. Gen. J. Hallera 107, 80-416 Gdask, Poland 
   
2 
 
Laboratory of Environmental Chemometrics, Faculty of Chemistry, University of Gdask, ul. Wita Stwosza 63, 80-308 Gdask, Poland 
   
3 
 
Department of Endocrinology and Internal Medicine, Medical University of Gdask, ul. Dbinki 7, 80-211 Gdask, Poland 
   
4 
 
Department ofEnvironmental Analytics,Institute for Environmental and Human Health Protection, Faculty of Chemistry, University of Gdask, ul. Wita Stwosza 63, 80-308 Gdask, Poland 
    
* 
 
Author to whom correspondence should be <EVENT eid="e2" class="OCCURRENCE">addressed</EVENT>. 
   
Academic Editor: Ting-Li (Morgan) Han 
 
Received: <TIMEX3 tid="t1" type="DATE" value="2016-12-05">5 December 2016</TIMEX3> / <EVENT eid="e3" class="OCCURRENCE">Revised</EVENT>: <TIMEX3 tid="t2" type="DATE" value="X">9</TIMEX3> January <TIMEX3 tid="t3" type="DATE" value="2017">2017</TIMEX3> / Accepted: 19 <TIMEX3 tid="t4" type="DATE" value="2017-01">January 2017</TIMEX3> / Published: 29 <TIMEX3 tid="t5" type="DATE" value="2017-01">January 2017</TIMEX3> 
 
No 
   
Cushings syndrome (CS) is a disease which results from excessive levels of cortisol in the human body. The <EVENT eid="e4" class="OCCURRENCE">disorder</EVENT> is associated with various signs and symptoms which are also common for the general population not <EVENT eid="e5" class="OCCURRENCE">suffering</EVENT> from compound hypersecretion. Thus, more sensitive and selective methods are <EVENT eid="e6" class="I_ACTION">required</EVENT> for the diagnosis of CS. This follow-up study was <EVENT eid="e7" class="I_STATE">conducted</EVENT> to <EVENT eid="e8" class="I_ACTION">determine</EVENT> which steroid metabolites could <EVENT eid="e9" class="OCCURRENCE">serve</EVENT> as potential indicators of CS and possible subclinical hypercortisolism in patients diagnosed with so called non-functioning adrenal incidentalomas (AIs). Urine samples from negative controls ( n = 37), patients with CS <EVENT eid="e10" class="OCCURRENCE">characterized</EVENT> by hypercortisolism and excluding iatrogenic CS ( n = 16), and patients with non-functioning AIs with possible subclinical Cushings syndrome ( n = 25) were <EVENT eid="e11" class="OCCURRENCE">analyzed using</EVENT> gas chromatography-mass spectrometry (GC/MS) and gas chromatograph <EVENT eid="e12" class="OCCURRENCE">equipped</EVENT> with flame ionization detector (GC/FID). Statistical and multivariate methods were <EVENT eid="e13" class="I_ACTION">applied</EVENT> to <EVENT eid="e14" class="I_ACTION">investigate</EVENT> the profile differences between examined individuals. The analyses <EVENT eid="e15" class="OCCURRENCE">revealed</EVENT> hormonal differences between patients with CS and the rest of examined individuals. The concentrations of selected metabolites of cortisol, androgens, and pregnenetriol were elevated whereas the levels of tetrahydrocortisone were <EVENT eid="e16" class="OCCURRENCE">decreased</EVENT> for CS when <EVENT eid="e17" class="OCCURRENCE">opposed</EVENT> to the rest of the study population. Moreover, after analysis of potential confounding factors, it was also possible to <EVENT eid="e18" class="OCCURRENCE">distinguish</EVENT> six steroid <EVENT eid="e19" class="OCCURRENCE">hormones</EVENT> which <EVENT eid="e20" class="OCCURRENCE">discriminated</EVENT> CS patients from other study subjects. The obtained discriminant functions <EVENT eid="e21" class="OCCURRENCE">enabled</EVENT> classification of CS patients and AI group <EVENT eid="e22" class="OCCURRENCE">characterized</EVENT> by mild hypersecretion of cortisol metabolites. It can be <EVENT eid="e23" class="I_ACTION">concluded</EVENT> that steroid hormones selected by <EVENT eid="e24" class="OCCURRENCE">applying</EVENT> urinary profiling may <EVENT eid="e25" class="OCCURRENCE">serve</EVENT> the role of potential biomarkers of CS and can <EVENT eid="e26" class="OCCURRENCE">aid</EVENT> in its early diagnosis. 
 This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly <EVENT eid="e27" class="OCCURRENCE">cited</EVENT>. (CC BY 4.0).    Never miss any articles <EVENT eid="e28" class="OCCURRENCE">matching</EVENT> your research from any publisher  Get <EVENT eid="e29" class="OCCURRENCE">alerts</EVENT> for new papers matching your research  Find out the new papers from selected authors  Updated daily for 49'000+ journals and <TIMEX3 tid="t6" type="DATE" value="X">6000</TIMEX3>+ publishers  Define your Scifeed now     
MDPI and ACS Style 
 
Kotowska, A.; Puzyn, T.; Sworczak, K.; Stepnowski, P.; Szefer, P. Metabolomic Biomarkers in Urine of Cushings Syndrome Patients. Int. J. Mol. Sci.  2017 , 18 , 294. 
 AMA Style 
Kotowska A, Puzyn T, Sworczak K, Stepnowski P, Szefer P. Metabolomic Biomarkers in Urine of Cushings Syndrome Patients. International Journal of Molecular Sciences . 2017; 18(2):294. 
 Chicago/Turabian Style 
Kotowska, Alicja; Puzyn, Tomasz; Sworczak, Krzysztof; Stepnowski, Piotr; Szefer, Piotr. 2017. "Metabolomic Biomarkers in Urine of Cushings Syndrome Patients." Int. J. Mol. Sci. 18, no. 2: 294. 
  
Show more citation formats  Show less citations formats 
  
Note that from the first issue of <TIMEX3 tid="t7" type="DATE" value="2016">2016</TIMEX3>, MDPI journals <EVENT eid="e30" class="OCCURRENCE">use</EVENT> article numbers instead of page numbers. See further details here . 
     
Article metric data <EVENT eid="e31" class="STATE">becomes</EVENT> available approximately <TIMEX3 tid="t8" type="DURATION" value="PT24H">24 hours</TIMEX3> after publication online. 
  
No 
 
No 
 [Return to top]
</TEXT>


<MAKEINSTANCE eiid="ie19" eventID="e19" pos="NOUN" tense="NONE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie18" eventID="e18" pos="VERB" tense="INFINITIVE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie31" eventID="e31" pos="UNKNOWN" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie30" eventID="e30" pos="VERB" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie11" eventID="e11" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie10" eventID="e10" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie13" eventID="e13" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie12" eventID="e12" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie15" eventID="e15" pos="UNKNOWN" tense="PAST" aspect="NONE" polarity="NEG" modality="N/A" />
<MAKEINSTANCE eiid="ie14" eventID="e14" pos="VERB" tense="INFINITIVE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie17" eventID="e17" pos="UNKNOWN" tense="PAST" aspect="NONE" polarity="NEG" modality="N/A" />
<MAKEINSTANCE eiid="ie16" eventID="e16" pos="UNKNOWN" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie9" eventID="e9" pos="VERB" tense="FUTURE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie8" eventID="e8" pos="VERB" tense="INFINITIVE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie5" eventID="e5" pos="VERB" tense="PRESPART" aspect="NONE" polarity="NEG" modality="N/A" />
<MAKEINSTANCE eiid="ie4" eventID="e4" pos="NOUN" tense="NONE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie7" eventID="e7" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie6" eventID="e6" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie1" eventID="e1" pos="VERB" tense="PRESPART" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie3" eventID="e3" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie2" eventID="e2" pos="UNKNOWN" tense="FUTURE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie24" eventID="e24" pos="VERB" tense="PRESPART" aspect="NONE" polarity="NEG" modality="N/A" />
<MAKEINSTANCE eiid="ie25" eventID="e25" pos="VERB" tense="FUTURE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie26" eventID="e26" pos="VERB" tense="FUTURE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie27" eventID="e27" pos="VERB" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie20" eventID="e20" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie21" eventID="e21" pos="UNKNOWN" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie22" eventID="e22" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie23" eventID="e23" pos="VERB" tense="FUTURE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie28" eventID="e28" pos="VERB" tense="PRESPART" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie29" eventID="e29" pos="VERB" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />

<TLINK lid="TL0" eventInstanceID="ie31" relatedToTime="t8" relType="DURING" />
</TimeML>
